Objectives:

1. Review the immune response to malignancy, with a focus on what is known of the immune response to lymphoma
2. Discuss known mechanisms of immune surveillance escape and exploitation with immunotherapy
3. Review clinical evidence for current use of immunotherapy for NHL and identify future research directions